Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
The search for melanoma biomarkers is crucial, as the incidence of melanoma continues to rise. We have previously demonstrated that serum CEACAM1 (sCEACAM1) is secreted from melanoma cells and correlates with disease progression in metastatic melanoma patients. Here, we have used a different cohort...
Saved in:
Main Authors: | Sapoznik Sivan, Faranesh Suzan, Ortenberg Rona, Hamburger Tamar, Barak Vivian, Peretz Tamar, Schachter Jacob, Markel Gal, Lotem Michal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/290536 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
by: R. Ortenberg, et al.
Published: (2015-01-01) -
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
by: Michal Lotem, et al.
Published: (2016-01-01) -
Focus on Adoptive T Cell Transfer Trials in Melanoma
by: Liat Hershkovitz, et al.
Published: (2010-01-01) -
On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
by: Andreea Calinescu, et al.
Published: (2018-01-01) -
Thigmotropism of Malignant Melanoma Cells
by: Pascale Quatresooz, et al.
Published: (2012-01-01)